Registry of Osteogenesis Imperfecta

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLuca Sangiorgi

About this trial

ROI is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different sources evaluating several aspects of diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.

Eligibility criteria

Qualifiers

All Osteogenesis Imperfecta patients, including prenatal and fetal diagnosis of Osteogenesis Imperfecta

Disqualifiers

Any condition unrelated to Osteogenesis Imperfecta

Trial design

Treatments tested in this trial

  • bisphosphonates

Treatment groups

5,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

Luca Sangiorgi

Lead sponsor

Istituto Ortopedico Rizzoli

Sponsor institution